TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›GEHC›Financials
Annual statements · SEC XBRL · FY2021 – FY2025

GE HealthCare Technologies Inc. (GEHC) financials

Income statement

GE HealthCare Technologies Inc. (GEHC) income statement, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$17.6B$18.3B$19.6B$19.7B$20.6B
Revenue growth—4.3%6.6%0.6%4.8%
Gross profit$7.17B$7.18B$7.92B$8.21B$8.25B
Gross margin40.8%39.1%40.5%41.7%40.0%
Operating income$2.79B$2.52B$2.44B$2.63B$2.76B
Operating margin15.9%13.8%12.5%13.3%13.4%
Net income$2.25B$1.92B$1.57B$1.99B$2.08B
Net margin12.8%10.4%8.0%10.1%10.1%
EPS (diluted)$4.95$4.22$3.03$4.34$4.55

Cash flow

GE HealthCare Technologies Inc. (GEHC) cash flow, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Operating cash flow$1.61B$2.13B$2.10B$1.96B$1.99B
Capital expenditures$248M$310M$387M$401M$482M
Free cash flow$1.36B$1.82B$1.71B$1.55B$1.50B
Share buybacks——$0.00$0.00$200M
Dividends paid$0.00$0.00$41.0M$55.0M$64.0M

Balance sheet

GE HealthCare Technologies Inc. (GEHC) balance sheet, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Cash & equivalents$561M$1.44B$2.49B$2.87B$4.49B
Total assets—$27.5B$32.5B$33.1B$36.9B
Total liabilities—$17.9B$25.1B$24.4B$26.3B
Long-term debt—$8.23B$8.44B$7.45B$9.49B
Shareholders' equity$16.7B$9.36B$7.13B$8.45B$10.4B
Retained earnings—$0.00$1.33B$3.26B$5.28B
Shares (wtd avg diluted)454M454M458M459M458M

Every figure is extracted from GE HealthCare Technologies Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is GE HealthCare Technologies Inc.'s annual revenue?
GE HealthCare Technologies Inc. (GEHC) reported $20.6B of revenue for fiscal year 2025 — up 4.8% from $19.7B in FY2024, per its annual report filed with the SEC.
Is GE HealthCare Technologies Inc. profitable?
Yes — GEHC earned $2.08B of net income in FY2025, a 10.1% net margin, per SEC filings.
What is GE HealthCare Technologies Inc.'s free cash flow?
$1.50B in FY2025 (operating cash flow $1.99B minus $482M of capital expenditures), from the SEC cash-flow statement.
Does GEHC pay a dividend?
Yes — GE HealthCare Technologies Inc. paid $64.0M in cash dividends during FY2025, per its SEC cash-flow statement.
Full GEHC analysis — verdict, score & filings →Is GEHC a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.